Oslo, 8 October 2026 - Observe Medical ASA (OSE: OBSRV) ("the Company" or "Observe Medical") is pleased to invite investors, analysts and other stakeholders to a presentation and trading update on Tuesday, 10 November 2026.
The presentation will take place virtually at 10:00 CET and will be streamed via webcast at the following link: https://qcnl.tv/p/NAjGJcoaq4K7jHYMejf9xQ
The main focus of the presentation will be an update on the Company's inbound order trajectory and commercial progress following the launch of UnoMeter Safeti Max, including initial market feedback and insights from recent industry events and customer engagements.
The presentation will be followed by a Q&A session.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.